Poultry India Expo at Hyderabad between November 27 & 30, 2018 reaffirmed Ceva Polchem’s footprints in Indian market. It was 12th Edition of Poultry India, one of the biggest show of Indian subcontinent. Notwithstanding tough competition from MNCs and Indian vaccine manufacturers, Transmune IBD & Vectormune ND vaccines could evoke positive interest among visitors including key Indian integrators and strategic customers like Japfa, CP & Tyson.
The footfall this year exceeded 40,000 with 300 plus exhibitors spread over 5 big halls and important visitors from Nepal, Srilanka and Bangladesh. Desvac Dovac machine on display attracted many small and medium scale broiler integrators from India. Broiler placement of more than 3 billion per annum with CAGR of over 8%, India offers innumerable opportunities for Ceva vaccines. Ceva Polchem team is looking forward to make clear difference in Indian subcontinent by way of effective ND-IBD control among broilers employing novel C.H.I.C.K program for hatchery vaccinations. Ceva Polchem’s flagship bioemulsifier, Liposorb was also on display to register a strong reminder to broiler integrators and feed millers.
Please visit Ceva Polchem, for more India news update.